#JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis https://t.co/zdehQVk93z https://t.co/XhVVzykXXN
8,076 followers
7,568 followers
RT @jitcancer: New #JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tum…
8,076 followers
New #JITC Review: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis https://t.co/zdehQVk93z https://t.co/nNzcxN5P1T
438 followers
RT @nanudasmd: The narrative between IRAEs and checkpoint inhibitor efficacy continues to evolve. Teasing out specific sites of IRAEs and b…